Growing Prevalence of Respiratory Diseases Market
Respiratory devices are medical equipment used for the treatment, monitoring and diagnosis of various respiratory diseases. Key respiratory devices include ventilators, oxygen concentrators, nebulizers, inhalers, Respitory Management Devices (RMDs) and masks. Ventilators are critical care equipment used for patients who cannot breathe or maintain oxygenation on their own due to severe lung infections or chronic obstructive pulmonary diseases (COPD). Oxygen concentrators are portable devices that extract oxygen from room air and deliver it to patients through nasal cannulas or masks. Nebulizers are used to administer respiratory medicines in the form of fine liquid mist that can reach deep inside the lungs. Inhalers allow the delivery of bronchodilators and preventive medications directly to the airways. The global respiratory devices market is estimated to be valued at US$ 23701.98 Mn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030.
Market Dynamics:
One of the key drivers for the respiratory devices market is the growing prevalence of respiratory diseases. According to the Global Burden of Disease Study, respiratory diseases accounted for 16.7 million deaths globally in 2016. COPD alone affected over 251 million people worldwide in 2016. Rising air pollution levels, tobacco smoking, increasing ageing population are some of the major factors contributing to the increasing burden of respiratory diseases. Moreover, the outbreak of COVID-19 pandemic has further increased the demand for ventilators and oxygen support devices globally. Ventilator production witnessed over 10 times growth during the peak of the pandemic. The growing patient pool with respiratory diseases is expected to drive significant demand for respiratory devices over the forecast period.
SWOT Analysis
Strength: Respiratory devices provide life-saving treatments for patients with respiratory diseases and conditions. The wide range of devices like devices for asthma, COPD, OSA and medications for respiratory diseases help patients manage their conditions. The growing respiratory diseases burden globally increases the demand for such devices. Manufacturers are investing in R&D to develop innovative respiratory solutions with improved patient outcomes.
Weakness: Respiratory devices are generally expensive which makes it difficult for many patients to afford prolonged treatment. Equipment like CPAP and BiPAP machines require regular maintenance which increases the overall cost of treatment. The lack of awareness about respiratory conditions in developing regions also impacts the market growth to some extent.
Opportunity: Rapid urbanization, aging population, rising pollution and changing lifestyles leading to sedentary habits are major drivers boosting the burden of respiratory diseases worldwide. This presents significant opportunities for market players to cater to the rising demand. Growing healthcare infrastructure and spending in emerging nations also opens up new markets. Telemedicine provides an opportunity to reach out to wider population.
Threats: Stringent regulatory processes and clinical testing delays new product launches, restricting market growth. Reimbursement issues pose challenges especially in developing nations. Economic slowdowns can impact the discretionary healthcare spending on such devices. Substitute technologies can pose a threat to established device categories.
Key Takeaways
The Global Respiratory Devices Market Growth is expected to witness high over the forecast period of 2023 to 2030 supported by rising disease burden, growing aging population, urbanization and changing lifestyles. The market size is expected to cross US$ 23701.98 Mn by 2023, growing at a CAGR of 13%.
Regional analysis: North America currently dominates the market owing to high disease prevalence, advanced healthcare infrastructure and growing R&D investments. Asia Pacific region is expected to exhibit fastest growth led by growing geriatric population, improving access to healthcare and rising lifestyle diseases in major country markets like China and India. Increasing healthcare expenditure, expansion of insurance coverage and adoption of innovative respiratory therapies will further boost the APAC respiratory devices market.
Key players: Key players operating in the respiratory devices market are TCS, Wipro, Cognizant, Infosys, IBM, Qualitest, CGI, Mindtree, Cygnet Infotech, Maveric Systems, QA Mentor, A1QA, QA Source, QASource, Capgemini, Accenture, HCL Technologies, Atos, DXC Technology, Tech Mahindra. These companies are focused on developing innovative respiratory solutions through R&D and partnerships. Strategic mergers and acquisitions remain important growth strategies adopted by market players.
Explore more information on this topic, Please visit -
https://www.pressreleasebulletin.com/respiratory-devices-market-forecasts-and-growth-analysis/
Explore more trending article related this topic -